SCHEMBL6493579

SCHEMBL6493579

Nc1ccc2nc(-c3cc(Cl)c(N)c(Cl)c3)[nH]c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 1.00
GAA P10253 11/20 1.00
MEN1 O00255 9/20 1.00
KMT2A Q03164 9/20 1.00
ALDH1A1 P00352 9/20 1.00
SMN1; SMN2 Q16637 8/20 1.00
NPC1 O15118 8/20 1.00
RAB9A P51151 8/20 1.00
HPGD P15428 8/20 1.00
POLB P06746 6/20 1.00
TP53 P04637 5/20 1.00
BLM P54132 4/20 1.00
HTT P42858 3/20 1.00
KDM4E B2RXH2 9/20 0.74
USP2 O75604 3/20 0.74
TDP1 Q9NUW8 3/20 0.74
CACNA1B Q00975 2/20 0.74
APBA1 Q02410 2/20 0.74
THRB P10828 2/20 0.74
LMNA P02545 2/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6493573 0.88 ALDH1A1 (0.78) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL3205897 0.86 MEN1 (0.81) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL6483421 0.85 MEN1 (1.00) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL2251258 0.83 MEN1 (1.00) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL26731643 0.83 MEN1 (1.00) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL20982512 0.82 MEN1 (0.96) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL363703 0.82 MEN1 (1.00) MAPTGAAMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL3199369 0.81 MEN1 (0.97) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL30215952 0.79 GAA (0.66) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL11746078 0.79 GAA (0.66) MAPTGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP MAPT 7/4885GAA 381/4885MEN1 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.